A new era? Biocon is stepping into India's generic GLP‑1 market, aiming for affordable diabetes and weight‑loss solutions. CEO Tambe reports strong earnings growth, hinting at a future shift in metabolic care. What does this mean for patients?

🚩 #Biocon #HealthTech #DiabetesCare

Biocon founder Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor, outlining leadership transition and future strategy for the biotech major. https://english.mathrubhumi.com/news/money/who-is-claire-mazumdar-biocon-founder-names-her-heir-sv91hb72?utm_source=dlvr.it&utm_medium=mastodon #Biocon #KiranMazumdarShaw
Before you continue to YouTube